Our customers include many of the leading research institutions and life science companies throughout the world. The Company’s products and technologies are used in a wide variety of applications within the areas of neurobiology, cell signaling, oncology, angiogenesis, apoptosis, developmental biology, cellular physiology, hematology, immunology, cardiology, infectious diseases and molecular biology.

Serologicals® Corporation is the leading supplier of cell culture supplements that accelerate the movement of critical therapeutic drugs and medical devices from the laboratory to the marketplace. Serologicals’ cell culture family is led by EX-CYTE®, a growth enhancing supplement proven to boost protein production. In addition, Serologicals® is the largest worldwide supplier of bovine serum albumin and leading provider of recombinant human insulin for cell culture applications to the biotech industry. State-of-the-art facilities and five decades of experience enable us to deliver products with the highest quality, performance and safety.

Chemicon International, Inc., became a division of Serologicals Corporation in April 2003. Chemicon provides a broad range of specialty reagents, kits, antibodies and molecular biology tools to biotech, pharma and academic research customers working in the areas of neuroscience, infectious disease, drug discovery, cancer research, stem cell research and proteomics. The Company is also a leading supplier of monoclonal antibodies, conjugates, antibody blends and kits for use in the diagnostic laboratory. Chemicon has a proven track-record of being able to successfully identify, develop, manufacture, and commercialize new products very quickly, and introduced more than 500 new products during 2002.

From a strategic standpoint:

Chemicon's product and customer base greatly enhances Serologicals' product offering of molecular biology and diagnostic reagent products, as well as greatly enhancing the presence of Serologicals in the research element of the biomedical product pipeline, which complements the Company's strong presence in the development and production phases.